UPSHER SMITH LABS FDA Approval ANDA 085088

ANDA 085088

UPSHER SMITH LABS

FDA Drug Application

Application #085088

Application Sponsors

ANDA 085088UPSHER SMITH LABS

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL50MG0HYDRALAZINE HYDROCHLORIDEHYDRALAZINE HYDROCHLORIDE

FDA Submissions

ORIG1AP1994-09-16
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1983-04-07
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1983-04-07
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1983-04-07
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1983-04-07
MANUF (CMC); Manufacturing (CMC)SUPPL17AP1983-02-22
MANUF (CMC); Manufacturing (CMC)SUPPL18AP1983-02-22
MANUF (CMC); Manufacturing (CMC)SUPPL19AP1983-11-03
MANUF (CMC); Manufacturing (CMC)SUPPL20AP1983-11-03

Submissions Property Types

SUPPL8Null0
SUPPL11Null0
SUPPL12Null0
SUPPL14Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0

CDER Filings

UPSHER SMITH LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 85088
            [companyName] => UPSHER SMITH LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"HYDRALAZINE HYDROCHLORIDE","activeIngredients":"HYDRALAZINE HYDROCHLORIDE","strength":"50MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"HYDRALAZINE HYDROCHLORIDE","submission":"HYDRALAZINE HYDROCHLORIDE","actionType":"50MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.